If you have been reading about reversed-phase HPLC and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-10-25. Where a claim depends on a specific study, the study is described rather than over-claimed.
Melanotan-2, also written Melanotan II, is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, and the lactam bridge between the aspartate and lysine side chains constrains the peptide into a ring. This structural change increases receptor affinity and metabolic stability relative to the native hormone. The compound was created in the 1980s as a research tool for studying pigmentation biology.
Melanocytes are the pigment-producing cells of the skin, and they carry melanocortin-1 receptors on their surface. When the receptor is activated, cyclic adenosine monophosphate rises inside the cell and raises the activity of enzymes such as tyrosinase, which increases melanin output. Melanotan-2 binds melanocortin-1 receptors in vitro and in animal models, and this binding is generally described as the basis for the tanning effect. Other receptors account for different effects: melanocortin-4 receptors contribute to appetite and erectile signalling, while melanocortin-3 and melanocortin-5 receptors contribute to energy balance and exocrine function.
Early published reports described melanotan-2 as a tanning agent without sun protection, which means darkening is not the same as protection against ultraviolet radiation. Later studies explored the peptide in erectile dysfunction, hemorrhagic shock, and some skin conditions. No regulator in the United States or Europe has approved it for clinical use. Many products labelled melanotan-2 are sold without approval and their identity and purity are unverified. Its long-term safety in humans remains an open question.
Analytical confirmation of identity relies on mass spectrometry, most often coupled to liquid chromatography. Reversed-phase high-performance liquid chromatography separates the peptide from related impurities and provides a purity estimate based on peak area. Electrospray ionization mass spectrometry then confirms the expected molecular mass, while tandem mass spectrometry can map the fragment sequence. For research-grade material, these two techniques together form the standard minimum. Purity figures reported by vendors are frequently not traceable to an independent laboratory.
Independent verification is central to quality control because the compound is not produced under pharmaceutical manufacturing standards. Third-party laboratories can measure purity, identity, residual solvents, and microbial contamination, though the scope of testing varies between services. Reported analyses of vendor samples have shown batch-to-batch variation in peptide content and the presence of truncated or oxidized species. How much of this variation reflects synthesis conditions versus storage and shipping is not well characterized. No harmonized reference standard exists for the material as sold.
| Property | Value | Notes |
|---|---|---|
| Compound class | Synthetic cyclic heptapeptide | Alpha-MSH analogue containing a D-phenylalanine residue |
| Molecular formula | C50H69N15O9 | Average molecular mass approximately 1024.2 g/mol |
| Appearance | White to off-white lyophilised powder | Normally supplied as a freeze-dried solid in a sealed vial |
| Solubility | Freely soluble in water and polar solvents | Dissolves readily in aqueous buffers and in alcohol-water mixtures |
| Receptor targets | MC1R, MC3R, MC4R, MC5R | Acts as a non-selective melanocortin receptor agonist |
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry. Retention time supports identity, while the mass spectrum confirms the molecular weight of the intact peptide. Purity is frequently reported as a percentage of total peak area, a figure that depends on the wavelength, column and gradient used. Impurity profiling may also look for truncated sequences, oxidised forms and residual counterions. Amino acid analysis and peptide mapping provide orthogonal confirmation when required.
Regulatory status varies by jurisdiction, and the substance is frequently described as unapproved for therapeutic use. Some authorities classify it alongside prescription-only medicines or controlled categories, while others address it through general consumer protection rules. Analytical surveys have reported mismatches between label claims and measured content in products sold online, although the scope of such testing is limited. Whether these discrepancies are widespread remains an open question. Discussion in the literature therefore tends to combine chemistry, supply-chain observation and policy analysis.
Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.
The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.
==== Mucous glands ==== Mucous glands are non-venomous and offer a different functionality for amphibians than granular. Mucous glands cover the entire surface area of the amphibian body and specialize in keeping the body lubricated. There are many other functions of the mucous glands such as controlling the pH, thermoregulation, adhesive properties to the environment, anti-predator behaviors (slimy to the grasp), chemical communication, even anti-bacterial/viral properties for protection against pathogens. The ducts of the mucous gland appear as cylindrical vertical tubes that break through the epidermal layer to the surface of the skin. The cells lining the inside of the ducts are oriented with their longitudinal axis forming 90-degree angles surrounding the duct in a helical fashion. Intercalary cells react identically to those of granular glands but on a smaller scale. Among the amphibians, there are taxa which contain a modified intercalary region (depending on the function of the glands), yet the majority share the same structure. The alveolar or mucous glands are much more simple and only consist of an epithelium layer as well as connective tissue which forms a cover over the gland. This gland lacks a tunica propria and appears to have delicate and intricate fibers which pass over the gland's muscle and epithelial layers.
Another phase commonly encountered in the study of chemistry is the aqueous phase, which is the state of substances dissolved in aqueous solution (that is, in water). Less familiar phases include plasmas, Bose–Einstein condensates and fermionic condensates and the paramagnetic and ferromagnetic phases of magnetic materials. While most familiar phases deal with three-dimensional systems, it is also possible to define analogs in two-dimensional systems, which has received attention for its relevance to systems in biology.
== Drug nomenclature for radiopharmaceuticals == As with other pharmaceutical drugs, there is standardization of the drug nomenclature for radiopharmaceuticals, although various standards coexist. The International Nonproprietary Name (INN) gives the base drug name, followed by the radioisotope (as mass number, no space, element symbol) in parentheses with no superscript, followed by the ligand (if any). It is common to see square brackets and superscript superimposed onto the INN name, because chemical nomenclature (such as IUPAC nomenclature) uses those. The United States Pharmacopeia (USP) name gives the base drug name, followed by the radioisotope (as element symbol, space, mass number) with no parentheses, no hyphen, and no superscript, followed by the ligand (if any). The USP style is not the INN style, despite their being described as one and the same in some publications (e.g., AMA, whose style for radiopharmaceuticals matches the USP style). The United States Pharmacopeial Convention is a sponsor organization of the USAN Council, and the USAN for a given drug is often the same as the USP name.
=== Poisoning of Emilian Gebrev === In the aftermath of the Skripal poisoning, investigative journalists were able to track some of the people involved also in Bulgaria. This is how another suspected poisoning case dating back to April 2015 during their stay in the country was linked to the Novichok nerve agent. The victim was the Bulgarian arms dealer Emilian Gebrev, who shared two hypotheses why he might have been attacked: The first one links to the fact that his arms manufacturing company Dunarit exports defense equipment to Ukraine. The other one relates to an attempt by an offshore company to take over Dunarit. The takeover attempt was ultimately linked to the influential Bulgarian politician and oligarch Delyan Peevski who has historically been funded by Russia's state-owned VTB Bank. In November 2023 Bulgaria sought the extradition of three Russian GRU officers, Sergey Fedotov, Georgi Gorshkov and Sergey Pavlov, suspected of the poisoning incident. Sergei Fedotov was also the alias used by one of the assassins in the Salisbury poisonings.
Sources: en.wikipedia.org
=== February === 1 February Mike Behrens, lawyer and judge, King's Counsel (since 1999), District Court judge (2004–2011) (born 1941). Dame Iritana Tāwhiwhirangi, Māori language advocate (born 1929). 2 February – Peter Babich, Hall of Fame viticulturist and businessman (born 1932). 5 February – Brian Turner, field hockey player (national team), poet and environmental campaigner, Commonwealth Poetry Prize (1999), Poet Laureate (2003–2005) (born 1944). 6 February – Jim Cole, volcanologist (University of Canterbury), Fellow of the Royal Society of New Zealand (since 2004) (born 1941). 7 February – Ian Barton, forester, heritage advocate (Queen's Redoubt Trust), and local-body politician, Franklin District Councillor (1998–2004) (born 1937). 10 February Lynne Giddings, nursing and women's studies academic (Auckland University of Technology, University of Auckland) (born 1945). Toni Huata, Māori musician (born 1969). Rod McElrea, racing driver, national beach racing champion (1971), OSCA champion (1983) (born 1941). 12 February – Theo Janssen, sculptor, stained-glass artist and painter (born 1934). 13 February – Joe Pope, business executive (Petrocorp, ENZA) and rugby administrator, chair of Hurricanes franchise (1999–2003) and Wellington Rugby Football Union (2003–2009) (born 1941). 15 February David Ellison, Māori leader (Kāti Huirapa), veterans' welfare and children's health advocate (born 1936). David Parsons, musician, composer and ethnomusicologist (born 1944). 17 February – David Saunders, lawyer and judge, District Court judge (1993–2020) (born c. 1951).
"Aged only 45. it seemed that Robertson had many years of brilliant work ahead of him. His vast investigations into fundamental principles of bio-chemistry, especially the physical chemistry of the proteins and the chemical basis of growth and senescence had equipped him in a unique manner for the attack which he was making upon the immense problems of animal nutrition in Australia. For the time being he was concentrating upon the sheep, working along fundamental lines in his laboratory and applying and testing the results on a large scale at field stations ... He was about to extend this work very considerably during the present year, and one knows that he had completely won the confidence of the graziers in the States in which he was working and was assured of the unstinted support in his plans. ... No one can estimate the seriousness of the check which his sudden passing has given to scientific work in connection with the pastoral industry of Australia, and, indeed, to science generally." A.C. David Rivett, Chief Executive Officer of CSIR, 20 January 1930. "His premature death, at the comparatively early age of forty-five years, removes one of the most active and valuable workers from biochemical research, and is a very serious loss to the recently instituted movement for the more rapid application of biological knowledge to the development of animal husbandry in Australia." James B. Overton, Professor of Plant Physiology at the University of Wisconsin, Nature. "Biological science has lost, in Robertson, one of its most brilliant and energetic exponents. ...
15 January – Denis Connaghan, 79, footballer (Celtic, St Mirren, Morton). (death announced on this date) 27 January – Stuart Gray, 50, footballer (Celtic, Reading, Rushden & Diamonds), cancer. (death announced on this date) 30 January – Ally Shewan, 83, footballer (Aberdeen) and manager (Elgin City). (death announced on this date) 4 February – Mallorca Lee, 51, DJ, producer, (Ultra-Sonic), (Public Domain). 9 February – Peter Handyside, 49, footballer (Grimsby Town, Stoke City, Barnsley). 16 February – Ian McMillan, 92, footballer (Airdrieonians, Rangers, national team). (death announced on this date) 23 February – Harry Melrose, 88, footballer (Dunfermline Athletic, Aberdeen, Berwick Rangers) and manager. (death announced on this date) 24 February – Stewart Robertson, 75, conductor. (death announced on this date) 29 February – Tiffany Scott, 32, sex offender and transgender prisoner. 7 March – Nick Sheridan, 32, Irish journalist and television presenter (News2day, Reporting Scotland, The Nine) (Death announced on this date) 14 March – Angela McCluskey, 64, Scottish singer (Wild Colonials) and songwriter ("Breathe"). 15 March – Peter Kelly, 82, Scottish actor (The Tall Guy, Welcome to Sarajevo). 18 March – Peter McAleese, 81, Scottish soldier and mercenary. 20 March – Billy Kellock, 70, Scottish footballer (Cardiff City, Peterborough United, Wolverhampton Wanderers). 29 March – Iain McChesney, 79, Scottish footballer (Queen of the South). 14 April – Vincent Friell, 64, Scottish actor (Trainspotting, Restless Natives, The Angels' Share).
As with cocaine in Coca-Cola, lithium was widely marketed as one of several patent medicine products popular in the late 19th and early 20th centuries and was claimed to be included in many drinks including lithia water and 7 Up. Charles Leiper Grigg, who launched his St. Louis-based company The Howdy Corporation, invented a formula for a lemon-lime soft drink in 1920. The product, at one point named "7Up Lithiated Lemon Soda", was launched two weeks before the Wall Street Crash of 1929. It claimed to contain the mood stabilizer lithium citrate, and was one of many patent medicine products popular in the late-19th and early-20th centuries. All references to lithium were removed in 1937 after it became clear that 7Up contains no lithium. Many sources written by scientists (instead of historians) incorrectly report that 7 Up was forced to remove lithium in 1948, with an FDA action that supposedly banned lithium from beverages. Despite the supposed ban, in 1950, the Painesville Telegraph still carried an advertisement for a lithiated lemon beverage.
== Awards == 2014 – Akabori Memorial Award (Japanese Peptide Society) 2016 – Max Bergmann Gold Medal (German Peptide Society) 2016 – Nippon Venture Award (METI) 2017 – Nagoya Silver Medal of Organic Chemistry (MSD Life Science Foundation) 2019 – Vincent du Vigneaud Award (American Peptide Society) 2020 – Humboldt Prize (Humboldt Foundation) 2020 – World Entrepreneur of the Year, Japan (EY) 2022 – Prelog Medal (ETH Zurich) 2023 – Wolf Prize in Chemistry (Wolf Foundation) 2024 – Asian Scientist 100 (Asian Scientist) 2026 – Elected a Fellow of the Royal Society
Sources: en.wikipedia.org
insertional mutagenesis The alteration of a DNA sequence by the insertion of one or more nucleotides into the sequence, either naturally or artificially. Depending on the precise location of the insertion within the target sequence, insertions may partially or totally inactivate or even upregulate a gene product or biochemical pathway, or they may be neutral, leading to no substantive changes at all. Many genetic engineering techniques rely on the insertion of exogenous genetic material into host cells in order to study gene function and expression.
The meeting went from bad to worse, with Thiệu having a meltdown as he broke down in tears and hysterically accused Kissinger of plotting with the Soviet Union and China to betray him, saying he could never accept this peace agreement. Kissinger's statement that "Had we wanted to see you out, there would have been many easier ways by which we could have accomplished this" did not improve the mood. Thiệu later stated that he wanted to punch Kissinger in the face at that meeting. Thiệu refused to sign the peace agreement and demanded very extensive amendments that, as Kissinger reported to Nixon, "verge on insanity". Nixon ordered Kissinger to "push Thiệu as far as possible", but Thiệu refused to sign the peace agreement. Thiệu refused to see Kissinger the next day. Kissinger told one of Thieu's aides, Hoang Duc Nha, on the phone: "I am the special envoy of the President of the United States of America. You know I cannot be treated as an errand boy". Nha replied: "We never considered you an errand boy, but if that's what you think you are, there's nothing I can do about it". As Kissinger returned to Washington, one of his aides recalled: "In twenty-four hours, the bottom fell out". Though Nixon had initially supported Kissinger against Thiệu, two of his most influential advisers, namely his chief of staff, H.R. Haldeman and the Domestic Affairs Adviser John Ehrlichman, urged him to reconsider, arguing that Kissinger had given away too much and that Thiệu's objections had merit.
While blast and lymphoma cells can be identified in the manual differential, microscopic examination cannot reliably determine the cells' hematopoietic lineage. This information is often necessary for diagnosing blood cancers. After abnormal cells are identified, additional techniques such as immunophenotyping by flow cytometry can be used to identify markers that provide additional information about the cells.
N-Hydroxysuccinimide (NHS) is an organic compound with the formula (CH2CO)2NOH. It is a white solid that is used as a reagent for preparing active esters in peptide synthesis. It can be synthesized by heating succinic anhydride with hydroxylamine or hydroxylamine hydrochloride.
Sources: en.wikipedia.org
No. It is a laboratory-made peptide, while the natural hormone is alpha-melanocyte-stimulating hormone, a longer peptide produced by the pituitary gland and by skin cells. Melanotan-2 mimics only a short active region of that hormone and contains non-natural residues such as D-phenylalanine.
No approved regulatory indication exists in major markets. An approval exists for a different peptide, afamelanotide, which is used for a rare photosensitivity disorder called erythropoietic protoporphyria. Melanotan-2 itself remains a research compound with no cleared clinical role.
Melanocortin-1 receptors on melanocytes are the receptor most closely linked to pigment production. The peptide is not selective, however, and also activates melanocortin-3, melanocortin-4, and melanocortin-5 receptors. That lack of selectivity is the usual explanation offered for both its range of observed effects and its off-target effects.
The lyophilized powder is generally held at minus twenty degrees Celsius or below, away from light and moisture. Reconstituted solutions are typically refrigerated and used quickly. These practices derive from general peptide handling rather than a formal stability study.